CCND1 and breast cancer: The inactivation of PI3K/AKT signaling modulated by beta-naphthoflavone inhibited cyclinD1/D3 and cyclin-dependent kinase 4 (CDK4), resulted in cell cycle arrest in breast cancer cells [72].